Home/Filings/4/0000905148-24-001777
4//SEC Filing

TOMSICEK MICHAEL JOHN 4

Accession 0000905148-24-001777

CIK 0001781174other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 5:28 PM ET

Size

16.2 KB

Accession

0000905148-24-001777

Insider Transaction Report

Form 4
Period: 2024-06-20
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-20+20,27520,275 total
    Exercise: $6.52Exp: 2034-06-19Common Stock (20,275 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0001570392

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 5:28 PM ET
Size
16.2 KB